KRAIG BIOCRAFT LABS INC - KBLB STOCK NEWS

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) announces successful completion of the first pilot production test using a new two strain hybrid system, leading to increased vigor and significantly larger cocoon size. The company plans to transition all spider silk production to this model, aiming to increase silk production per rearing cycle and improve the quality of finished silk.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) has successfully started the production season with the delivery of the most recent batch of recombinant spider silk. The Company's CEO, Kim Thompson, is optimistic about meeting production targets for 2024, following the early production. The successful effort reinforces the Company's planned production model, accelerating plans for the upcoming 2024 production season and beyond.

Kraig Biocraft Laboratories, Inc. (KBLB) prepares for the spring rearing season in Vietnam, focusing on strengthening its team, facilities, and supply chain integration. The Company's senior management team is en route to Vietnam to meet with its subsidiary, Prodigy Textiles, third party contractors, and government officials, including provincial leadership. The Company plans to implement advanced rearing protocols across all operations domestically and overseas, leveraging the winter offseason to ensure ideal conditions for the 2024 season.

Kraig Biocraft Laboratories, Inc. (KBLB) continues to invest in building its team with leading sericulture consultants from India to enhance spider silk production. The experts will provide onsite training, strengthen rearing operations, and support field testing to improve production yields and increase throughput. The company is actively developing pure-line silkworm strains utilizing its recombinant spider silk technology.

Kraig Biocraft Labs hires key scientists from UND spider silk research lab, creating synergies in molecular biology and sericulture. The merger strengthens expertise in spider silk manufacturing. Company aims for larger-scale production and commercialization of spider silks.

Kraig Biocraft Labs announces management shakeup at its Vietnamese subsidiary, Prodigy Textiles, to support large-scale spider silk manufacturing. Changes aim to improve efficiencies and encourage innovation. Spider silk technologies ready for large-scale production.

Kraig Biocraft Laboratories announces the hiring of two key researchers with extensive sericulture experience. The new staff members have introduced new protocols that could reduce the rearing cycle by up to 40% and improve screening methods for silkworm health. These advancements may accelerate the delivery of the Company's production system and increase throughput in their U.S. facility.

Kraig Biocraft Laboratories (OTCQB: KBLB) announced its preparation for a response to the U.S. Air Force under the Defense Production Act Investments program. This initiative aims to bolster U.S. bio-industrial manufacturing capabilities, specifically targeting materials like spider silk. Kraig Labs is set to submit its detailed response by April 19, 2023. While this does not guarantee funding or a proposal request, it signifies the growing interest in biomanufactured materials. COO Jon Rice expressed optimism about Kraig's role in enhancing domestic biomanufacturing and updating the DoD on its advancements.

Kraig Biocraft Laboratories (OTCQB: KBLB) has announced the creation of two senior-level genetic engineering positions within its research and development team in the U.S. This expansion aims to enhance the team's capabilities, accelerating the development of spider silk technologies. The company expects these new roles will significantly increase research throughput, allowing for faster transition from concept to production for various spider silk protein designs. COO Jon Rice emphasized the potential for advancing new materials and transgenics in this exciting phase for the company.